Xeris Pharmaceuticals | XERS - Trade Debtors


Xeris Pharmaceuticals reported $56.29M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Celltrion KRW 2.01T 39.71B Mar/2026
Cspc Pharmaceutical CNY 8.79B 64.64M Dec/2025
Deva Holding AS TRY 3.03B 343.23M Sep/2023
Dianthus Therapeutics USD 1.23M 1.18M Mar/2026
Divis Laboratories Ltd INR 29.99B 3.71B Mar/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
Kangmei Pharma CNY 2.92B 228.09M Mar/2026
Knight Therapeutics CAD 183M 7.46M Dec/2025
Laboratorios Farma EUR 143.38M 16.93M Dec/2023
Malin Corporation EUR 500K 300K Dec/2024
Medical Developments International AUD 7.48M 174K Dec/2025
Nektar Therapeutics USD 3.6M 1.82M Mar/2026
Neuren Pharmaceuticals AUD 26.54M 5.83M Dec/2025
Organigram Holdings CAD 53.39M 3.45M Mar/2026
Ovoca Bio EUR 53K 14K Dec/2025
Pacira USD 132.42M 6.78M Jun/2026
Perrigo USD 697.1M 84.3M Mar/2026
Pharma Mar EUR 58.06M 6.87M Jun/2026
Qiagen NV USD 396.62M 5.99M Mar/2026
Sartorius EUR 381.2M 14.6M Jun/2026
Sino Biopharmaceutical CNY 8.45B 3.18B Jun/2025
Supernus Pharmaceuticals USD 211.66M 29.47M Jun/2026
Tilray USD 109.07M 2M Sep/2025
Zealand Pharma A/S 259M 81M Mar/2026
Zz Pientze Pharmaceu CNY 1.06B 60.42M Mar/2026